Summary:

• The global stereotactic surgery devices market size reached USD 25.5 Billion in 2023.
• The market is expected to reach USD 38.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.52% during 2024-2032.
• North America leads the market, accounting for the largest stereotactic surgery devices market share.
• Linear accelerator (LINAC) machine accounts for the majority of the market share in the product type segment due to their versatility in treating a variety of cancers. 
• Based on the application, the market has been divided into brain tumor treatment, arteriovenous malformations treatment, Parkinson’s disease, epilepsy, and trigeminal neuralgia.
• The growing incidences of neurological disorders across the globe is a primary driver of the stereotactic surgery devices market.
• Technological advancements in imaging technologies is reshaping the stereotactic surgery devices market.

Request for a sample copy of this report: https://www.imarcgroup.com/stereotactic-surgery-devices-market/requestsample

Industry Trends and Drivers:

• Increasing Prevalence of Neurological Disorders:

The rising prevalence of neurological disorders, such as Parkinson’s disease, epilepsy, and brain tumors, is one of the major factors boosting the market growth. These conditions require precise and minimally invasive (MI) interventions, boosting the need for stereotactic surgery. Moreover, the heightened demand for treatment options with lower risks and quicker recovery times, spurring the adoption of stereotactic techniques over conventional surgical procedures, is catalyzing the market growth. Additionally, the growing geriatric population, which is more susceptible to neurodegenerative diseases, driving the need for advanced treatment methods, is acting as a growth-inducing factor. Besides this, the rising recognition among governments and healthcare organizations of the need for improved neurological care, leading to better healthcare infrastructure and the availability of advanced medical technologies, is driving the market growth.

• Rapid Technological Advancements in Imaging and Surgical Navigation:

The rising advancements in imaging technologies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans that improve the accuracy and outcomes of stereotactic surgeries, are creating a positive outlook for the market. These imaging techniques allow for precise three-dimensional (3D) mapping of the brain, enabling surgeons to target affected areas with minimal disruption to surrounding tissues. Moreover, the development of real-time imaging and robotic assistance during surgery that enhance the precision of these procedures is catalyzing the market growth. These innovations reduce the risk of complications and increase the success rates of surgeries, making stereotactic surgery devices more attractive to healthcare providers and patients.

• Rising Demand for Minimally Invasive (MI) Procedures:

The widespread popularity of minimally invasive surgical procedures due to their numerous benefits, such as reduced pain, shorter recovery times, and fewer complications, is stimulating the market growth. Moreover, the heightened application of stereotactic surgery, as it offers precision that allows for targeted interventions without the need for large incisions, is strengthening the market growth. Moreover, the growing demand for stereotactic procedures and patients as it enables faster recovery, reduced hospital stays, and lower healthcare costs, is contributing to the market growth. In addition to this, the burgeoning adoption of stereotactic surgery devices in hospitals and surgical centers to meet patient demand for less invasive options is supporting the market growth.

Stereotactic Surgery Devices Market Report Segmentation:

We explore the factors propelling the stereotactic surgery devices market growth, including technological advancements, consumer behaviors, and regulatory changes.

Breakup By Product Type:

• Gamma Knife
• Linear Accelerator (LINAC) Machine
• Proton Beam
• Cyberknife 

Linear accelerator (LINAC) machine account for the majority of shares as they are widely used in stereotactic radiosurgery due to their precision in targeting tumors with minimal damage to surrounding tissues.

Breakup By Application:

• Brain Tumor Treatment
• Arteriovenous Malformations Treatment
• Parkinson’s Disease
• Epilepsy
• Trigeminal Neuralgia 

Based on the application, the market has been divided into brain tumor treatment, arteriovenous malformations treatment, Parkinson’s disease, epilepsy, and trigeminal neuralgia.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America holds the leading position owing to a large market for stereotactic surgery devices driven by its advanced healthcare infrastructure, high healthcare expenditure, rising prevalence of neurological disorders, and the presence of major medical device companies.

Top Stereotactic Surgery Devices Market Leaders:

The stereotactic surgery devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

• Accuray Incorporated
• Elekta
• Hitachi Ltd.
• Mevion Medical Systems
• Shinva Medical Instrument Co. Ltd
• Varian Medical Systems Inc. (Siemens Healthineers)

Ask Analyst & Browse full report with TOC List of Figures: https://www.imarcgroup.com/request?type=report&id=12608&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145